Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youki Ueda

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 26, 2022
[Clonal Evolution in the Tumor Microenvironment]Youki Ueda, Yosuke Togashi
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 27, 2021
Extracellular vesicles activate ATM-Chk2 signaling pathway through the intercellular transfer of mitochondrial DNA in HBV-infected human hepatocytesHiromichi Dansako, Youki Ueda, Shinya Satoh, et al.
Biochemical and Biophysical Research Communications|May 31, 2011
Plural assay systems derived from different cell lines and hepatitis C virus strains are required for the objective evaluation of anti-hepatitis C virus reagentsYouki Ueda, Kyoko Mori, Yasuo Ariumi, et al.
Biochemical and Biophysical Research Communications|September 14, 2018
Daunorubicin, a topoisomerase II poison, suppresses viral production of hepatitis B virus by inducing cGAS-dependent innate immune responseHirotaka Imai, Hiromichi Dansako, Youki Ueda, et al.
Biochemical and Biophysical Research Communications|September 16, 2020
Identification of ribavirin-responsive cis-elements for GPAM suppression in the GPAM genomeDaichi Onomura, Shinya Satoh, Youki Ueda, et al.
FASEB Bioadvances|May 12, 2021
Antiviral mechanism of preclinical antimalarial compounds possessing multiple antiviral activitiesWeilin Gu, Youki Ueda, Hiromichi Dansako, et al.
Virus Genes|January 19, 2012
Development of a drug assay system with hepatitis C virus genome derived from a patient with acute hepatitis CKyoko Mori, Youki Ueda, Yasuo Ariumi, et al.
FASEB Bioadvances|March 4, 2020
High-level expression of STING restricts susceptibility to HBV by mediating type III IFN inductionHiromichi Dansako, Hirotaka Imai, Youki Ueda, et al.
Biochemical and Biophysical Research Communications|April 15, 2014
Anti-HCV activity of the Chinese medicinal fungus Cordyceps militarisYouki Ueda, Kyoko Mori, Shinya Satoh, et al.
FEBS Open Bio|March 8, 2018
ULBP1 is induced by hepatitis C virus infection and is the target of the NK cell-mediated innate immune response in human hepatocytesHiromichi Dansako, Hirotaka Imai, Youki Ueda, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 26, 2022
[Clonal Evolution in the Tumor Microenvironment]Youki Ueda, Yosuke Togashi
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 27, 2021
Extracellular vesicles activate ATM-Chk2 signaling pathway through the intercellular transfer of mitochondrial DNA in HBV-infected human hepatocytesHiromichi Dansako, Youki Ueda, Shinya Satoh, et al.
Biochemical and Biophysical Research Communications|May 31, 2011
Plural assay systems derived from different cell lines and hepatitis C virus strains are required for the objective evaluation of anti-hepatitis C virus reagentsYouki Ueda, Kyoko Mori, Yasuo Ariumi, et al.
Biochemical and Biophysical Research Communications|September 14, 2018
Daunorubicin, a topoisomerase II poison, suppresses viral production of hepatitis B virus by inducing cGAS-dependent innate immune responseHirotaka Imai, Hiromichi Dansako, Youki Ueda, et al.
Biochemical and Biophysical Research Communications|September 16, 2020
Identification of ribavirin-responsive cis-elements for GPAM suppression in the GPAM genomeDaichi Onomura, Shinya Satoh, Youki Ueda, et al.
FASEB Bioadvances|May 12, 2021
Antiviral mechanism of preclinical antimalarial compounds possessing multiple antiviral activitiesWeilin Gu, Youki Ueda, Hiromichi Dansako, et al.
Virus Genes|January 19, 2012
Development of a drug assay system with hepatitis C virus genome derived from a patient with acute hepatitis CKyoko Mori, Youki Ueda, Yasuo Ariumi, et al.
FASEB Bioadvances|March 4, 2020
High-level expression of STING restricts susceptibility to HBV by mediating type III IFN inductionHiromichi Dansako, Hirotaka Imai, Youki Ueda, et al.
Biochemical and Biophysical Research Communications|April 15, 2014
Anti-HCV activity of the Chinese medicinal fungus Cordyceps militarisYouki Ueda, Kyoko Mori, Shinya Satoh, et al.
FEBS Open Bio|March 8, 2018
ULBP1 is induced by hepatitis C virus infection and is the target of the NK cell-mediated innate immune response in human hepatocytesHiromichi Dansako, Hirotaka Imai, Youki Ueda, et al.
Pageof 4